(Q48682941)

14 February 2018

title

Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers (English)

1 reference

14 February 2018

1 reference

2

1 reference

14 February 2018

author name string

Emmanuel Krupka

1

1 reference

14 February 2018

Claire Lafay

3

1 reference

14 February 2018

David Gendre

4

1 reference

14 February 2018

Bertrand Diquet

5

1 reference

14 February 2018

Serge Bouquet

6

1 reference

14 February 2018

Marie-Christine Perault

7

1 reference

14 February 2018

publication date

11 July 2006

1 reference

14 February 2018

European Journal of Clinical Pharmacology

published in

1 reference

14 February 2018

volume

62

1 reference

14 February 2018

issue

8

1 reference

14 February 2018

page(s)

653-659

1 reference

14 February 2018

Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0159-2

Effect on postural sway of various benzodiazepine tranquillizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0159-2

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0159-2

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-006-0159-2

Standardization in platform stabilometry being a part of posturography

21 January 2018

1 reference

12 December 2020

Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe.

1 reference

12 December 2020

Effect of age, gender, and obesity on midazolam kinetics.

1 reference

12 December 2020

Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A.

1 reference

12 December 2020

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

1 reference

12 December 2020

First-pass metabolism of midazolam by the human intestine.

1 reference

12 December 2020

Midazolam. A review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

1 reference

12 December 2020

1 reference

12 December 2020

In vitro and in vivo drug interactions involving human CYP3A.

1 reference

12 December 2020

Pharmacokinetics of midazolam in the aged.

1 reference

12 December 2020

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration

1 reference

12 December 2020

Noninvasive tests of CYP3A enzymes

1 reference

12 December 2020

Validity of the Mini-Mental State examination as a screening instrument for cognitive impairment and dementia in French elderly community residents.

1 reference

12 December 2020

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

1 reference

12 December 2020

Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers

1 reference

12 December 2020

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

1 reference

12 December 2020

10.1007/S00228-006-0159-2

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018